Integral membrane proteins (IMPs) link the cell to its environment and the constituencies of cell compartments to their functional pathways. They are importantly involved in ion transport, signaling and cell adhesion [1] . Owing to their central gate-keeping role, their functional and structural characterization is crucial to molecular and medical biology. Most common are alpha-helical IMPs (alpha-IMPs) that span the membrane by inserting long (15-40 residues) alpha helices [2] . These alpha-IMPs constitute about 25% of all proteins, a fraction that is surprisingly constant and varies more within the domains of life than between them [3, 4] .
In contrast to soluble proteins that interact with the aqueous solution of the cell, IMPs interact with at least three different environments: the hydrophobic core of the membrane, the charged head groups of lipids and the aqueous solution on both sides of the membrane. The fact that IMPs have been shaped by evolution to be stable under these particular conditions poses one of the enormous challenges for their experimental structure determination. Protein flexibility and low expression levels further add to the problems. This helps explaining why the class of proteins that is targeted by most drugs is structurally the most under-represented: alpha-IMPs constitute less than 2% of all proteins in the Protein Data Bank (PDB) [5] [6] [7] [8] . Solving a single high-resolution structure for an alpha-IMP may take years of meticulous optimization of protein constructs and experimental conditions. In this review of the progress in structure determination for alpha-IMPs, we focus on polytopic alphaIMPs, that is, IMPs with at least two transmembrane helices. These constitute about 70% of all alpha-IMPs [3, 9] .
Structural genomics for IMPs?
At the beginning of the millennium Structural Genomics (SG), the marriage between the world of sequences and the world of structures took off [10, 11] . One important objective was to increase the impact of protein structure on biology, another to reduce the costs of structure determination through robotics (high-throughput cloning, expression and purification), and yet another to increase the structural coverage of sequence space by picking targets with a high impact upon comparative modeling [12, 13] .
Initially, SG initiatives would target so-called 'low-hanging fruits', that is, proteins whose structures were perceived to be easier to solve. Large SG centers have consistently determined several structures every day over the last five years. But the low-hanging fruits story ended with the focus of several new centers shifting to membrane proteins. Only proteins with long natively disordered regions seem to be even more elusive to structure determination [14] .
The first SG center specializing in membrane proteins, the European Membrane Protein Consortium (E-MeP), (Table 1) with some of the centers focusing on proteins from specific families or related to particular processes, for example, the G-protein coupled receptor (GPCR) network and the Center for Membrane Proteins of Infectious Diseases (MPID).
Progress in structure determination for membrane proteins
Despite the experimental challenges, the number of new experimental IMP structures has been increasing remarkably [8] with 170 new polytopic alpha-IMP structures added to the PDB in 2011 as compared to 31 in 2001. It should be stressed however that many of these new entries were either similar or identical in sequence to IMPs previously in the PDB. Solving structures for new members of structurally covered families is often extremely useful, since homology models cannot always provide the level of resolution that may be required for downstream functional studies. The most obvious example is represented by targets of outstanding biomedical interest such as GPCRs for which two additional structures have recently been solved by the GPCR network [15, 16 ].
Our main objective in this opinion, however, is to assess progress in determining novel IMP structures. (Table 2) , almost half of which were added over the last five years ( Figure 1 ). These data show that, despite clear progress, determining IMP structures for new Pfam families is still extremely challenging.
After the first years, much of the success in structure determination of IMPs has been achieved in Bacteria ( Figure 2 ). However, significant contributions also come from eukaryotic membrane protein structures. About 25% of the 101 Pfam families have structures for IMPs from more than one kingdom. In particular, we looked at structural coverage of polytopic alpha-IMP families in Homo sapiens (Figure 3 ). Note that 7% of human IMPs do not map to any Pfam family (Figure 3(a) ). We see that 10% of Pfam human IMP families have a structural representative, with one fifth of those having a structure for a human protein ( Figure 3(b) ).
SG contributes already significantly to IMP structure determination
Large SG consortia contributed over 13% of all structures to the PDB [18, 19] . Since IMP structures have not been on the list of SG for long, the impact on these is less impressive, albeit still significant (Table 2 ). In terms of novel leverage, SG has contributed the first structure for 7.5 Pfam families, or 7% of IMP families that are currently structurally covered ( Figure 1 , Table 2 ). Considering that SG work on IMPs started in earnest only in [2004] [2005] and that the number of consortia involved has increased only very recently, this can be already considered an important contribution. Furthermore, Figure 1 shows that Structural genomics for membrane proteins Kloppmann, Punta and Rost 327 the contribution of both SG and non-SG to novel leverage is increasing with time.
The Pfam families that have been covered first by SG are:
(1) CorA-like Mg 2+ transporter protein (PF01544) [20] , (2) the formate/nitrite transporter (PF01226, covered at the same time by non-SG) [21] , (3) the urea transporter (PF03253) [22] , (4) the amino acid permease (PF13520) [23] , (5) the C4-dicarboxylate transporter/ malic acid transport protein (PF03595, including the anion channel TehA) [24 ] , (6) the phosphotransferase system, EIIC (PF02378) [25] , (7) the cation transport protein, TrkH (PF02386) [26] , and finally, (8) the etoposide-induced protein 2.4 (EI24) (PF07264, PDB ID 3tx3).
In terms of the estimated number of models that can be built by comparative modeling from each new structure [27] , SG is lagging behind (5671 sequences/Pfam family for SG versus 13 591 sequences/Pfam family for non-SG). Interestingly, however, the median coverage of 3031 sequences for SG versus 3364 for non-SG suggests that once the bias due to the some large families is removed, the contribution to coverage is not very different.
SG finds the needle in the haystack
Expression, purification, stability, and crystallization outcomes can differ radically between very similar proteins even when subjected to the same experimental protocols executed by robots (Figure 4(a) ). As a consequence, targeting several family members can increase the likelihood of solving a structure for that family. Structural knowledge acquired on one member of the family can then be at least partially transferred to other members with the help of comparative modeling [27, 28, 29 ] . Thus, Figure 1 .
one experimental structure enables to study the basic sequence-structure-function relationships within the family. TehA, which is a homologue of the plant SLAC1 anion channel, is one remarkable recent example in which the structure of a H. influenzae protein (one of the highest resolution IMPs (1.2 Å ) in the PDB, contributed by SG) explained important aspects about the mechanism of closing stomata in plant leaves [24 ,30] . In the pictorial view of the channel crystal structure reported in Figure 4 (b), we highlight the highly conserved Phe262, which is implicated in the gating mechanism.
More in general, recalcitrance of individual IMPs to experimental structure determination makes the pangenomic, family-level approach of SG particularly relevant to their study. This is testified to by the fact that a similar approach has been adopted by a number of non-SG laboratories that target easier to handle bacterial IMPs instead of their functionally often better characterized eukaryotic relatives. A classic example is the structure of the bacterial KcsA potassium channel from S. lividans, the first high-resolution ion channel structure [31] .
SG contributes more than 'just' structures
The ultimate and most important objective of structural genomics is the determination of protein structures. However, all consortia have generated much additional value over the last decade. For instance, the large consortia cloned and tried to express at least one representative for most structurally uncovered short bacterial proteins [18, 32] .
SG consortia targeting IMPs have created pipelines that hold important value [33 ] . Over 15 000 IMPs have entered the SG pipelines ( Figure 5 ). Notwithstanding high attrition rates at essentially each of the experimental stages, SG has managed to express and purify several thousands of IMPs. As all protocols, reagents and proteins are made available, there is a large added potential value to SG that reaches substantially beyond solved structures. Targets that failed in the late stages of an SG pipeline may still be successfully pursued by experts in the field, when time is taken to optimize experimental conditions.
Computational challenges for SG of IMPs
Methods from bioinformatics and computational biology are heavily used in SG, primarily for target selection and downstream analysis of solved structures, including reconstruction of phylogenies, homology modeling and function annotation. Starting from an initial pool of protein sequences, target selection for IMPs typically proceeds as follows:
(1) Alpha-IMPs are separated from other proteins by methods that predict transmembrane helices
Structural genomics for membrane proteins Kloppmann, Punta and Rost 329 Table 2 IMP structure statistics. 'All' is the sum of SG and non-SG depositions. In the first row 'PDB IDs', we report all PDB IDs of polytopic alphaIMPs that we considered (see Figure 1 ). Row 'Pfam IDs', shows the number of Pfam families that overlap with the transmembrane region of the structures in row one. Row three 'Pfam IDs only in' reports unique Pfam family contributions (first structure deposited for that family) for SG and non-SG. Finally, row four 'Sequences in Pfam families' shows the total number of sequences belonging to the Pfam families in row four (full alignments). a One Pfam family, 'formate/nitrite transporter' (PF01226), was covered by an SG and non-SG structure at the same time, both structures were deposited in the PDB before the first was released. This family is counted with a factor of 0.5 for SG and non-SG. (TMHs) [34] . Consortia may choose to target proteins with at least two [9, 35] or more [36, 37] transmembrane helices. Although their performance has often been overestimated, methods that predict TMHs have largely matured. Open challenges include the correct identification of re-entrant elements, and more generally the identification of non-helical regions inserted into the membrane bilayer [38, 39] . (2) IMPs are then clustered into families such that one experimental structure in that family suffices to model structures for all family members using standard alignment methods. There is evidence that this is justified [40] . Recently, new tools have been developed that seem to improve alignments for membrane proteins [41] [42] [43] . This is most relevant for building better comparative models within a family covered by an experimental structure. (3) Finally, targets promising a higher success rate are selected. Until now, this step largely filtered out proteins dominated by long regions that are natively disordered or used prior knowledge about success in, for example, protein expression. Some methods try to predict how feasible a globular protein is for some aspects of structure determination pipelines [44] [45] [46] . Lack of experimental data has so far hindered the development of such a method for alpha-IMPs. Given the over 15 000 IMPs in SG pipelines ( Figure 5 ), it might be time to revisit this task.
All
Overall, we argue that for the purpose of SG, tasks (1) and (2) are sufficiently addressed by existing methods. The major challenge is task (3) , that is, the prediction of which protein in a family is the most promising candidate for getting a structure from a pipeline. This task also remains essentially unsolved for globular proteins, but for membrane proteins advances are more urgently needed because the resources that still have to be , and only one yielded a diffracting crystal and finally a high-resolution structure. Note in particular the dramatic attrition rate in the number of successfully cloned to successfully expressed proteins. Targets are cloned by ligation free cloning and C-terminal fusion expression vector. Expression and purification are assessed by Coomassie Blue stained SDS-PAGE gels and stability in the DMM detergent is determined by size exclusion chromatography [35] . Structures of the TehA family representative from H. influenzae have been solved and deposited in the PDB [24 ] . (b) Structure of the SLAC1 homolog TehA. The anion channel structure is shown as seen from the periplasm (PDB ID: 3m71, ribbon representation). The highly conserved Phe262 occluding the ion permeation pathway is shown explicitly. The figure is created using Chimera [50] . Statistics for IMP structural genomics protein production pipelines. Depicted is the number of IMPs that were successful at different stages in the experimental pipelines. Data were extracted from TargetDB [51] in January 2012 for nine membrane protein structural genomics consortia: CSMP, GPCR network, MPID, MPSbyNMR, MPSCB, NYCOMPS, TEMIPS, TMPC and TransportPDB. For the NMR consortium (MPSbyNMR) we do not report data for the steps following purification.
invested after the pipelines complete their work are considerable.
Another area in which further progress would be much welcome is prediction of functional attributes in proteins from sequence and structure. This information can be used in target selection to identify for example interaction partners (proteins or small molecules) that may be important for protein stability. In the same way, more accurate methods that predict protein function from sequence without using solely homology transfer would be extremely helpful. Finally, prediction from structure is important in cases in which a structure is solved for a functionally not annotated family.
Conclusion
Structural genomics has succeeded in plucking the highhanging fruits of integral transmembrane proteins. Projecting from the recent progress, there is little doubt that structural genomics will play an important role toward tackling this important challenge in structural biology.
Computational biology has contributed importantly to the recent experimental success, through methods that predict membrane regions and methods that align membrane proteins. Despite several challenges to those methods, the major challenge seems to be to develop better tools for prioritizing targets and for annotating function in the absence of homology information.
